Medicines/finished pharmaceutical products

Reference Number: 
HA114 (a)

Date of prequalification: 
20 March 2002
Basis of listing: 
Prequalified by WHO
Status: 
Active
INN: 
Zidovudine
Therapeutic area: 
HIV/AIDS
Dosage form & strength: 
Solution for injection 10mg/mL
Storage condition: 
Do not store above 30°C
Shelf life (months): 
36
Packaging: 
Vial, Type I glass: 20ml vial x5
Applicant: 
ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom of Great Britain and Northern Ireland
FPP Manufacturing Site: 

Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Harmire Road, Barnard Castle, County Durham, DL12 8DT, United Kingdom of Great Britain and Northern Ireland

FPP WHO Public Inspection Reports: 
API Manufacturing Site: 

(Zidovudine) Aurobindo Pharma Ltd, Unit VIII, Survey No. 10 & 13, Gaddapothoram Village, I.D.A Kazipally, Jinnaram Mandal, Sanga Reddy District, Telangana, 520319, India

API WHO Public Inspection Reports: